# Travere Therapeutics, Inc.: Form 8-K, filed May 6, 2024

- Company: [Travere Therapeutics, Inc.](/companies/tvtx.md) (CIK 1438533)
- Form: 8-K
- Filed: 2024-05-06
- Accepted by EDGAR: May 6, 2024, 20:05 ET
- Period: 2024-05-06
- Accession: 0001438533-24-000019
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1438533/000143853324000019/tvtx-20240506.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1438533/000143853324000019/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1438533/000143853324000019/tvtx-20240506.htm

Filed May 6, 2024.
Source: SEC EDGAR, the filing index for accession 0001438533-24-000019. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.